Welcome to our blog

I have been be overwhelmed by the prayer, love, kindness, support & generousity of everybody since Charlotte's diagnosis. Thank you so much!
Charlotte is under a shared care scheme with her minor chemo & general health looked after Poole General Hospital and the stronger chemo, procedures & overall treatment plan managed by the Piam Brown Ward at Southampton General Hospital. The ward is 1 of 22 specialist wards in the UK treating cancer in children.
If there is anything else you would like to know please don't hesitate ask or click on of the links below to find out more.
Charlotte's treatment is continual over 2 years & 2 months so its a long tough road ahead but through my faith I gather strength and remain positive (most of the time!)

2 Cor 12:9

Sunday 11 March 2012

CHILDHOOD CANCER FACTS

Despite how many children including Charlotte I know who have some form of cancer, Childhood cancer is described as RARE - around 1,500 new cases are diagnosed every year in the UK. This means that around one child in 500 will develop some form of cancer by the age of 14 years. The rarity of childhood cancer does impede funding & research. But there is hope for many - more than seven in 10 children diagnosed with cancer can now be cured.

 Types of Cancer

Charlotte has Acute Lymphoblastic Leukaemia the most common childhood cancer. Leukaemia (cancer of the blood) as a whole equates to *31% of child cancer cases, with Brain & Spinal tumours accounting for 25% (around 390 cases per year), its then quite a drop to Lymphomas (cancer starting in the lymphatic system) at 10% (around 160 cases per year).
Britain has the lowest childhood cancer rate in Europe, and one of the lowest of all western industrialized countries. Australia and the US have some of the highest rates. The reasons for this are not clear.


Breakdown by type of cancer
Relative contributions of main diagnostic groups of childhood cancer to overall incidence among children aged 0 to 14 years, Great Britain, 2001 to 2005
Based on data provided by National Registry of Childhood Tumours
(http://www.ccrg.ox.ac.uk/datasets/registrations.htm)

Different types of childhood cancer are most common at different ages.
Some types of cancer – including embryonal tumours (such as neuroblastoma, retinoblastoma and nephroblastoma) and acute lymphoblastic leukaemia (ALL) - occur most commonly in the under-fives. Others, such as bone tumours are very rare in younger children, increasing in incidence with age and peaking in adolescence.

Survival rates
Survival rates for the 12 main diagnostic groups vary between 96 per cent for retinoblastoma and 53 per cent for neuroblastoma. And within these main diagnostic groups, survival rates vary even more. Some rare sub-types of cancer have survival rates of zero.
Although Brain and Spinal tumours rank second in incidence, they rank highest in terms of the number of deaths from cancer in childhood. In the 10 years from 1995 to 2004, 1,115 children died as a result of CNS tumours, just under a third of all childhood cancer deaths. And, yet I’ve read somewhere else that the least is spent on it in research terms?
The Causes?
Despite a wealth of research, much uncertainty remains over the causes of childhood cancers.
Many different factors have been linked with the development of childhood cancer, with varying degrees of certainty.
Research is complicated by the fact that there are many different factors which may cause cancer in children. Exposure to more than one of these factors is probably necessary – and probably at different stages of a child’s life.
The relative rarity of childhood cancers further impedes research.
Leukaemia is better represented in research literature than other forms of cancer because it affects more children, making it easier to obtain meaningful results in epidemiological studies. International collaborations are important as they increase the number of cancer cases available for study.
Treatment
As well as finding new ways to treat those forms of cancer which still have a poor outlook, a major challenge facing doctors today is how to make treatments safer and minimise the risk of treatment-related harm in young patients.
Most children diagnosed with cancer in the UK will immediately be referred to one of 21 hospitals that are specialist centres for treating children’s cancer.
Doctors at the specialist centre will confirm the diagnosis and plan the child’s treatment. Some of the later treatment may be given at the family’s local hospital under the guidance of the specialist centre – this is known as shared care.
There are three main ways of treating cancer:
Solid tumours can be cut out during an operation (surgery)
Cancer cells can be killed with drugs (chemotherapy)
Cancer cells can be killed by radiation (radiotherapy)
Often a combination of these treatments is used.
Clinical trials
Many children have their treatment as part of a clinical research trial.
Trials aim to improve our understanding of the best way to treat childhood cancers – they usually compare the standard treatment with a new or modified version of the standard treatment. Information gathered from successive trials has been one of the most important factors in the increasing survival rates for childhood cancer.
Taking part in a clinical trial is entirely voluntary; the medical team will provide detailed information and you will be given plenty of time to decide whether it is right for your child. Children who do not take part will receive the current standard treatment.
Side effects and complications
Treatments for cancer involve high doses of toxic drugs and/or radiation. These therapies are effective in killing the deadly cancerous cells but unfortunately they can also damage normal, healthy cells, putting the child at risk of harmful side-effects.
Short-term side effects such as hair loss, nausea and anaemia are common but temporary problems. With good supportive care, they can be kept to a minimum.
But some children may experience more serious long-term effects, which persist for months or years after treatment, or ‘late’ effects which do not develop or become apparent until years after treatment ends. The risk of these effects varies from child to child, depending on the treatments used and the age and developmental stage of the child.
A major consideration in the development of new treatments is how to minimise the risk of harmful effects.


No comments:

Post a Comment